Drug intelligence / Profile preview

Xcid

Development stage
Unknown
Lead developer
Xieon Life Sciences
Modality
Small Molecules
01

Overview

Xcid is a brand name primarily used in the Indian pharmaceutical market for a range of gastrointestinal and anti-inflammatory medications. The brand encompasses several distinct formulations, most commonly gastrointestinal treatments: **Xcid Syrup**, a combination of magaldrate (an antacid) and simethicone (an anti-flatulent) used to relieve acidity and bloating; **Xcid D** and **Xcid DSR**, which combine the proton pump inhibitor (PPI) rabeprazole with the prokinetic agent domperidone for the management of gastroesophageal reflux disease (GERD) and peptic ulcers; and **Xcid L**, which pairs rabeprazole with levosulpiride. Additionally, the brand name is used for meloxicam, a non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation in conditions like arthritis. These medications work through multiple mechanisms, including the neutralization of gastric acid, inhibition of the H+/K+ ATPase pump to reduce acid secretion, antagonism of dopamine D2 receptors to enhance gastric motility, and inhibition of cyclooxygenase enzymes to reduce prostaglandin synthesis.

Brand names
XcidXcid DXcid DSRXcid LXcid Syrup
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)ATP4A (Potassium–transporting ATPase alpha chain 1)HTR4 (5-Hydroxytryptamine receptor 4)DRD2 (Dopamine D2 Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Xcid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xcid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call